Association of perioperative use of nonsteroidal anti-inflammatory drugs with postoperative myocardial infarction after total joint replacement

Regional Anesthesia and Pain Medicine

Volumn 37, Issue 1, 2012, Pages 45-50

  Liu, Spencer S ^a   Bae, James J ^a   Bieltz, Mihai ^a   Ma, Yan ^a   Memtsoudis, Stavros ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TROPONIN I;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KNEE PROSTHESIS; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; RISK; RISK FACTOR; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW YORK CITY; ODDS RATIO; PAIN, POSTOPERATIVE; PERIOPERATIVE PERIOD; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84855170995     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e31823354f5     Document Type: Article

References (37)

1. Hochman JS, Shah NR. What price pain relief? Circulation. 2006;113:2868-2870. (Pubitemid 44297226)
2. Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009;103:1227-1237.
3. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296:1633-1644. (Pubitemid 44511610)
4. Meunier A, Aspenberg P, Good L. Celecoxib does not appear to affect prosthesis fixation in total knee replacement: A randomized study using radiostereometry in 50 patients. Acta Orthop. 2009;80:46-50.
5. Baron JA, Sandler RS, Bresalier RS, et al. Cardiovascular events associated with rofecoxib: Final analysis of the APPROVe trial. Lancet. 2008;372:1756-1764.
6. Graham DJ. COX-2 inhibitors, other NSAIDs, and cardiovascular risk: The seduction of common sense. JAMA. 2006;296:1653-1656. (Pubitemid 44511613)
7. Kerr DJ, Dunn JA, Langman MJ, et al. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med. 2007;357:360-369. (Pubitemid 47124136)
8. Bueno H, Bardaji A, Patrignani P, et al. Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol. 2010;105:1102-1106.
9. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: A cohort study. Ann Intern Med. 2011;154:523-528.
10. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: A systematic review and meta-analysis. Anesthesiology. 2011;114:796-806.
11. Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: Meta-analysis of randomized controlled trials. Anesthesiology. 2005;102:1249-1260. (Pubitemid 40745845)
12. Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005;103:1296-1304. (Pubitemid 41692514)
13. Macfarlane AJ, Prasad GA, Chan VW, et al. Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res. 2009;467:2379-2402.
14. Liu SS, Bieltz M, Wukovits B, et al. Prospective survey of patient-controlled epidural analgesia with bupivacaine and hydromorphone in 3736 postoperative orthopedic patients. Reg Anesth Pain Med. 2010;35:351-354.
15. Asnis PD, Gardner MJ, Ranawat A, et al. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. J Arthroplasty. 2007;22:213-218. (Pubitemid 46162081)
16. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653. (Pubitemid 350182388)
17. Hosmer DW, Lemeshow S. A goodness-of-fit test for the multiple logistic regression model. Commun Stat. 1980;A10:1043-1069.
18. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Precision. Oxford, NY: Oxford University Press; 2003.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Son, Inc; 2000.
20. Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35:2052-2056. (Pubitemid 47326440)
21. Juni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis. Lancet. 2004;364:2021-2029. (Pubitemid 39593078)
22. Jones SF, Power I. Postoperative NSAIDs and COX-2 inhibitors: Cardiovascular risks and benefits. Br J Anaesth. 2005;95:281-284. (Pubitemid 41487335)
23. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: A meta-analysis of randomized clinical trials. Am J Cardiol. 2007;99:91-98. (Pubitemid 44969347)
24. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis. BMJ. 2005;330:1366.
25. Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation. 2006;113:2906-2913. (Pubitemid 44297231)
26. Solomon SD,Wittes J, Finn PV, et al. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis. Circulation. 2008;117:2104-2113. (Pubitemid 351572169)
27. Becker MC, Wang TH, Wisniewski L, et al. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009;157:606-612.
28. Beattie WS, Warriner CB, Etches R, et al. The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgetic morphine regime reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty. Anesth Analg. 1997;84:715-722. (Pubitemid 27147689)
29. Mantilla CB, Horlocker TT, Schroeder DR, et al. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140-1146. (Pubitemid 34462575)
30. Ford MK, Beattie WS,Wijeysundera DN. Systematic review: Prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med. 2010;152:26-35.
31. Gerber DR. Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care Med. 2008;36:1068-1074. (Pubitemid 351482650)
32. White PF, Kehlet H, Neal JM, et al. The role of the anesthesiologist in fast-track surgery: From multimodal analgesia to perioperative medical care. Anesth Analg. 2007;104:1380-1396, table of contents. (Pubitemid 46791272)
33. Macfarlane AJ, Prasad GA, Chan VW, et al. Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth. 2009;103:335-345.
34. Duellman TJ, Gaffigan C, Milbrandt JC, et al. Multi-modal, pre-emptive analgesia decreases the length of hospital stay following total joint arthroplasty. Orthopedics. 2009;32:167.
35. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: Focused update on perioperative beta-blocker therapyVa report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2007;104:15-26. (Pubitemid 46360414)
36. van Klei WA, Bryson GL, Yang H, et al. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology. 2009;111:717-724.
37. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: A randomized, controlled clinical trial. Br J Anaesth. 2010;104:305-312.